View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Project
29 June 2017

Virginia Cancer Specialists (VCS) Research Facility, Virginia

In June 2017, Virginia Cancer Specialists (VCS) opened a Phase I clinical research facility in Fairfax, Virginia.
Virginia Cancer Specialists' (VCS) Phase I clinical trials research facility was opened in June 2017. Credit: Virginia Cancer Specialists.
The facility includes four treatment chairs with special heating and massage features. Credit: Virginia Cancer Specialists.
The Phase I clinical trials facility accommodates oncologists, haematologists, oncology nurses and oncology pharmacists. Credit: Virginia Cancer Specialists.

In June 2017, Virginia Cancer Specialists (VCS) opened a Phase I clinical research facility in Fairfax, Virginia.

Free eBook
img

3 Key Tips for a Successful Design Build Project

With supply chain disruptions and inflation creating new challenges for delivery teams, design-build projects are booming. This e-book looks at the 3 essential tips a project delivery team must consider when delivering a successful Design Build project.
by Oracle
Enter your details here to receive your free eBook.

The state-of-the-art facility will provide the space and equipment required to carry out early-stage drug development and advanced cancer trial programmes. It will also enhance VCS’s cancer research programme by improving its overall Phase I clinical capabilities.

VCS’s Phase I clinical research facility details

The clinical facility has a total floor space of 4,000ft² and includes four treatment chairs equipped with special heating and massage features.

The site’s design provides a comfortable and peaceful environment while encouraging communication and bonding among patients.

Each of the facility’s treatment areas can be closed with curtains to offer private space for the patients.

Phase I clinical trials protocols often require patients to be present on-site for more than 12 hours. In such events, the facility can accommodate the resident’s family members and caregivers.

Among the staff employed at the facility are a team of physicians, data coordinators, nurses and clinical research coordinators.

The facility also employs pharmacists who can ensure strict adherence to testing standards and offer specialised nursing services round-the-clock to monitor patients.

Phase I clinical trials at the facility

VCS established the Phase I clinical facility in order to realise its long-term objective of turning the site into an Immuno-Oncology Centre of Excellence.

According to the company, Phase I clinical trials are usually only available at large academic research centres, and very few companies can offer Phase I services during the initial stages of drug development.

“The state-of-the-art facility will provide the space and equipment required to carry out early-stage drug development and advanced cancer trial programmes.”

The facility will allow VCS to focus on investigational immuno-oncology (I-O) trials while providing patients with access to promising new therapies.

The latest advancement in cancer research, I-O therapies have proven tolerability and strong responses after the completion of treatment in the cancer community.

Marketing commentary on Virginia Cancer Specialists

VCS is a cancer care and research centre based in Northern Virginia that has been carrying out Phase I clinical trials since 2013. It has been offering cancer treatment facilities to patients for more than 40 years.

The research centre has a total of nine offices across Northern Virginia, which aim to help achieve the best outcomes for patients. It also has a number of cancer specialists, including oncologists, haematologists, oncology nurses and oncology pharmacists.

The addition of the new facility enhances the VCS’s ability to provide novel early-stage studies, while also allowing the company to carry out trials and focus on promising new advancements such as immunotherapy.

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology